Stocks couldn’t quite break into positive territory in Tuesday’s session, and both theDow Jones Industrial Average(DJINDICES:^DJI) and the S&P 500 (SNPINDEX:^GSPC) indexes finished lower on the day.
Today’s stock market
Index
Percentage Change
Point Change
Dow
(0.03%)
(6.72)
S&P 500
(0.14%)
(3.38)
Data source: Yahoo! Finance.
Financial stocks gave back another small piece of the larger gains they’ve seen since the start of the year. Selling pressure in that industry pushed the Financial Select Sector SPDR ETF (NYSEMKT:XLF) lower by 0.3%. On the other hand, a solid uptick in gold prices sparked a 6.1% gain in the bullish bet on the precious metal, Direxion Daily Jr Gold Miners Bull 3X ETF (NYSEMKT:JNUG).
Top 5 Gold Stocks For 2018: Modine Manufacturing Company(MOD)
Advisors’ Opinion:
- [By Monica Gerson]
Modine Manufacturing Co. (NYSE: MOD) is projected to post its quarterly earnings at $0.32 per share on revenue of $351.33 million.
Navios Maritime Holdings Inc. (NYSE: NM) is expected to report a quarterly loss at $0.37 per share on revenue of $101.51 million.
Top 5 Gold Stocks For 2018: Galapagos NV(GLPG)
Advisors’ Opinion:
- [By David Zeiler]
Bill Patalon’s initial stock pick was Galapagos NV (Nasdaq ADR: GLPG), a Belgian biotech company.
Patalon was attracted to Galapagos’ strategy to target “orphan diseases,” afflictions that strike rarely and so often go ignored by the Big Pharma companies. He also liked that Galapagos had more than 50 drug discovery programs underway, and that it already had licensing agreements with several bigger players in the industry.
- [By Stephen Mack]
Galapagos NV (Nasdaq: GLPG) is our big winner so far, gaining 578.8% since Money Morning Executive Editor Bill Patalon shared his recommendation with Money Morning readers in April 2012. The S&P 500 has gained 75.4% in the same time. Bill has renewed his recommendation for the Belgian biotech several times over the years, saying in 2016 that it has “an established history of piling on gains.” With an average gain of 110% a year, it’s hard to argue with that.
Top 5 Gold Stocks For 2018: Xerox Corporation(XRX)
Advisors’ Opinion:
- [By Paul Ausick]
Xerox Corp. (NYSE: XRX) dropped about 23% on Tuesday to post a new 52-week low of $6.46 after closing at $8.73 on Friday. The dip was the result of the company’s completed separation into two firms this morning. After the early drop shares had gained around 17% by late afternoon, probably on the strength of a cash payment of $1.8 billion.
- [By Chris Lange]
The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was Xerox Corp. (NYSE: XRX) which rose 3.8% to $30.56. The stocks 52-week range is $22.90 to $30.76. Volume was 3.8 million compared to its average volume of 2.3 million.
Top 5 Gold Stocks For 2018: Kronos Worldwide Inc(KRO)
Advisors’ Opinion:
- [By Monica Gerson]
Kronos Worldwide, Inc. (NYSE: KRO) is projected to post a quarterly loss at $0.13 per share on revenue of $308.50 million.
Energen Corporation (NYSE: EGN) is estimated to post a quarterly loss at $0.67 per share on revenue of $122.91 million.
Top 5 Gold Stocks For 2018: Intuitive Surgical Inc.(ISRG)
Advisors’ Opinion:
- [By Joseph Hogue]
Enter Intuitive Surgical (Nasdaq: ISRG) and Da Vinci, a robotic arm that allows surgeons to operate with just a single incision less than an inch in size.
- [By Benzinga News Desk]
Microsoft (NASDAQ: MSFT) Reports Q4 EPS $0.69 vs. Est. $0.58, Rev. $22.64B vs. Est. $22.14B
Intuitive Surgical (NASDAQ: ISRG) Reports Q2 GAAP EPS $4.71, Adj. EPS $5.62 vs $4.97 Est., Sales $670.1M vs $540.7M Est.
Halliburton (NYSE: HAL) Q2 EPS ($0.14) vs ($0.19) est, Revenue $3.84B vs $3.75B est
Morgan Stanley (NYSE: MS) Q2 EPS $0.75 vs $0.59 est, Revenue $8.9B vs $8.3B est - [By Demitrios Kalogeropoulos]
As for individual stocks, IBM (NYSE:IBM) and Intuitive Surgical (NASDAQ:ISRG) attracted heavy investor interest following their quarterly earnings releases.
- [By George Budwell, Keith Speights, and Cory Renauer]
So, to help investors separate the wheat from the chaff, we asked our Foolish contributors which stocks they thought are worth owning until at least 2030. These three healthcare specialists recommended Medtronic (NYSE:MDT), Johnson & Johnson (NYSE:JNJ), andIntuitive Surgical (NASDAQ:ISRG). Read on to find out why.
